Page last updated: 2024-12-05

butyl chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

butyl chloride: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8005
CHEMBL ID47259
MeSH IDM0049659

Synonyms (79)

Synonym
wln: g4
butane, 1-chloro-
n-propylcarbinyl chloride
nsc8419
1-chlorobutane
nbc wormer
sure shot
chlorure de butyle
nci-c06155
n-butyl chloride
nsc-8419
109-69-3
butyl chloride
inchi=1/c4h9cl/c1-2-3-4-5/h2-4h2,1h
1-chloro-butane
NCGC00091059-01
hsdb 4167
einecs 203-696-6
chlorobutane, 1-
ccris 1389
ai3-15309
brn 1730909
chlorure de butyle [french]
nsc 8419
1-chlorobutane, anhydrous, 99.5%
CHEMBL47259
AKOS000118759
A802074
1-chloranylbutane
NCGC00091059-02
chlorobutane
butyl chloride [nf]
zp7r667sgd ,
n-chlorobutane [un1127] [flammable liquid]
4-01-00-00246 (beilstein handbook reference)
ec 203-696-6
n-chlorobutane
unii-zp7r667sgd
NCGC00258419-01
tox21_200865
STL163562
BBL012221
dtxsid8020206 ,
tox21_111072
cas-109-69-3
dtxcid00206
FT-0607645
butane, chloro-
25154-42-1
butylchoride
n-butyl chloride [green book]
n-butyl chloride [mi]
butyl chloride [hsdb]
n-c4h9cl
J-504525
n-chlorbutane
normal butyl chloride
chloromethylpropane
n-bucl
chloro-n-butane
n-butylchloride
n-butyl-chloride
mfcd00001009
1-chlorobutane, hplc grade
J-002316
F0001-0200
1-chlorobutane, for hplc, >=99.8%
1-chlorobutane, hplc grade, >=99.5%
1-chlorobutane, reagentplus(r), 99%
1-chlorobutane, purum, >=99.0% (gc)
1-chlorobutane, biotech. grade, for protein sequence analysis, >=99.8%
1-chlorobutane, p.a., 99%
DB11534
Q161608
EN300-19284
happy jack worm capsules
nbc kaps wormer
chlorobutanes
butane,chloro-

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency8.91250.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency79.43280.004023.8416100.0000AID485290
LuciferasePhotinus pyralis (common eastern firefly)Potency40.53340.007215.758889.3584AID624030
RAR-related orphan receptor gammaMus musculus (house mouse)Potency8.86370.006038.004119,952.5996AID1159521
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.95260.001318.074339.8107AID926; AID938
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency31.44970.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency62.75040.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency31.44970.003041.611522,387.1992AID1159552
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.24980.001530.607315,848.9004AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.01420.000229.305416,493.5996AID743069
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency50.11870.001019.414170.9645AID588537
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1145366Octanol-water partition coefficient, log P of the compound1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Application of SCAP to drug design. 1. Prediction of octanol-water partition coefficients using solvent-dependent conformational analyses.
AID162229Toxicity determined using Konemann's Industrial Pollutants Toxicity Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID37563Aneuploidy activity was determined; - indicates negative induction of aneuploidy in Aspergillus nidulans1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID19825Partition coefficient (logP)1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (22.22)18.7374
1990's6 (13.33)18.2507
2000's13 (28.89)29.6817
2010's14 (31.11)24.3611
2020's2 (4.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 77.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index77.48 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index131.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (77.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]